Pulmonary Vascular
-
Third trial supports sotatercept to treat PAH
Guidelines expert James R. Klinger, MD, FCCP, said that while the evidence of efficacy is clear, more research is needed to address questions regarding the optimal duration of therapy and the potential for disease progression if therapy is stopped.
-
Experts evaluate treatment of PAH in the sotatercept era
Zeenat Safdar, MD, FCCP, reviewed recent clinical trial data on the use of the activin-signaling inhibitor sotatercept in pulmonary arterial hypertension (PAH).
-
Small steps toward a noninvasive approach to pulmonary hypertension
Noninvasive imaging approaches, particularly echocardiography-based and CT scan-based main pulmonary artery diameter assessment, offer complementary insights into early PH detection and risk stratification.
-
Session to highlight identification and management of right ventricular failure
Jorge Velazco, MD, FCCP, will chair a Wednesday morning session on the basics of right ventricular failure pathophysiology, medical treatment, echocardiographic evaluation, and advanced management with mechanical circulatory support.
-
Session addresses complex pulmonary vascular challenges in cirrhosis
Yu Kuang (Julie) Lai, MD, detailed the diagnosis of hepatopulmonary syndrome and post-liver transplant hypoxemia during the session, which also reviewed portopulmonary hypertension.
-
Session to discuss the management of pulmonary disease during pregnancy
Lisa K. Moores, MD, FCCP, will present during a Tuesday afternoon session on how physiology during pregnancy alters the clinical presentation and management of pulmonary disorders.
-
Experts to spotlight considerations for mechanical circulatory support devices in cardiothoracic surgery
Karuna Puttur Rajkumar, MD, MBBS, will chair a Monday session on the initial evaluation, troubleshooting, and optimization of mechanical circulatory support in cardiothoracic surgery.
-
Experts to explore imaging modalities for the often-overlooked right heart
Navitha Ramesh, MD, MBBS, FCCP, will chair a session on available imaging techniques and considerations for evaluating the complex structure and function of the right ventricle.
-
Beyond the pump: Clinical and psychosocial dimensions of LVAD therapy
Advanced HFrEF carries high mortality, but LVAD therapy can improve survival, heart function, and quality of life.
-
Shared decision-making in PAH
Shared decision-making is a collaborative process where clinicians and patients make informed health care decisions together, balancing medical evidence with patient values, which is especially important in complex conditions like PAH.
-
Pooled data suggest sotatercept as novel disease-modifying therapy for PAH
Aaron B. Waxman, MD, PhD, FCCP, said he believes the drug will become a first-line therapy option, but questions remain regarding when to initiate treatment.
-
Turning the tide in right ventricular failure: The role of mechanical support
As mechanical circulatory support technologies advance, understanding the unique features of right-sided devices is essential for optimal patient selection.
